{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Ratna Sohanpal, Hilary Pinnock, Liz Steed, Karen Heslop-Marshall, Moira J Kelly, Claire Chan, Vari Wileman, Amy Barradell, Clarisse Dibao-Dina, Paulino Font Gilabert, Andy Healey, Richard Hooper, Kristie-Marie Mammoliti, Stefan Priebe, Mike Roberts, Vickie Rowland, Sarah Waseem, Sally Singh, Melanie Smuk, Martin Underwood, Patrick White, Nahel Yaziji & Stephanie JC Taylor.

Ratna Sohanpal ¹, Hilary Pinnock ², Liz Steed ¹, Karen Heslop-Marshall ³, Moira J Kelly ¹, Claire Chan ¹, Vari Wileman ⁴, Amy Barradell ⁵, Clarisse Dibao-Dina ⁶, Paulino Font Gilabert ⁷, Andy Healey ⁷, Richard Hooper ¹, Kristie-Marie Mammoliti ⁸, Stefan Priebe ¹, Mike Roberts ⁹, Vickie Rowland ¹⁰, Sarah Waseem, Sally Singh ⁵, Melanie Smuk ¹², Martin Underwood ¹³, Patrick White ¹⁴, Nahel Yaziji ⁷, Stephanie JC Taylor ^1,*

¹ Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
² Allergy and Respiratory Research Group, Usher Institute, The University of Edinburgh, Edinburgh, UK
³ Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK
⁴ School of Mental Health and Psychological Sciences, Institute of Psychiatry, King’s College London, London, UK
⁵ University Hospitals of Leicester NHS Trust, Leicester, UK
⁶ Faculté de médecine de Tours, Université de Tours, Tours, France
⁷ Health Service and Population Research Department, Institute of Psychiatry, King’s College London, London, UK
⁸ Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
⁹ Safer Care Victoria, Melbourne, Melbourne, VIC, Australia
¹⁰ University of the West of England, Bristol, UK
¹¹ Women’s Health Division, University College London Hospitals NHS Foundation Trust, London, UK
¹² Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK
¹³ Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
¹⁴ Department of Population Health, School of Population Health and Environmental Sciences, King’s College London, London, UK
^* Corresponding author Email: s.j.c.taylor@qmul.ac.uk

Disclosure of interests

Full disclosure of interests: Completed ICMJE forms for all authors, including all related interests, or available in the toolkit on the NIHR Journals Library report publication page at https://doi.org/10.3310/PAWA7221.

Primary conflicts of interest: Karen Heslop-Marshall received payment from GlaxoSmithKline plc (GSK) (Brentford, UK), AstraZeneca (Cambridge, UK) and Chiesi Farmaceutici (Parma, Italy) for online presentations. She also received payment from Boehringer Ingelheim (Ingelheim am Rhein, Germany) for development of patient information on mental health, payment for teaching on the Train the Trainer course for ILD, and payment from Nursing Times for writing article on cognitive–behavioural therapy (CBT) in respiratory patients. She received sponsorship support from GSK to attend the European Respiratory Society 2021 virtual meeting and has stock/shares in, and is Director of Pivotal Healthcare Education Limited (Newcastle Upon Tyne, UK) to provide online educational training company for CBT foundation course. Vari Wileman’s salary was funded by NIHR Collaborations for Leadership in Applied Health Research and Care North Thames (2017–20). Stefan Priebe was a member of the Health Technology Assessment (HTA) Mental, Psychological and Occupational Health Panel (2014–18). Mike Roberts has received an honorarium from the National Institute for Health and Care Research (NIHR) HTA programme (reference 15/153/02). Sally Singh’s institution has received grant funding for her involvement in the following NIHR projects: NIHR PG 202020, NIHR131015, NIHR 17/63/20, NIHR and UK Research and Innovation (UKRI) (administered by the Medical Research Council) MR/V02776X/1, NIHR HTA 17/129/02, NIHR PB-PG-0317-20032. In addition, Sally Singh’s institution has received grant funding for her involvement in the Wellcome PhD Programmes for Health Professionals, Programme LHIIP (reference 223512/Z/21/Z). She has received a speaker’s fee from Cipla Limited (Mumbai, India) and Singh has the following positions: British Thoracic Society Pulmonary Rehabilitation Statement Group (co-chairperson 2021–23), American Thoracic Society Pulmonary Rehabilitation Assembly (chairperson 2021–23), NIHR Clinical Doctoral Research Fellowship review panel (2019–present), World Health Organization (WHO) Development Group for COPD (packages of interventions for pulmonary rehabilitation) (2020–1), WHO Guideline Development Group Clinical Management – Clinical Guidance COVID-19 (2021), and Royal College of Physicians Clinical Lead Pulmonary Rehabilitation Services Accreditation Scheme and Pulmonary Rehabilitation Audit. Martin Underwood reports that he is chief investigator or co-investigator on multiple previous and current research grants from NIHR and Arthritis Research UK (London, UK), and is a co-investigator on grants funded by the Australian National Health and Medical Research Council (Canberra, ACT, Australia). Martin Underwood was a NIHR Senior Investigator until March 2021 and has received travel expenses for speaking at conferences from the professional organisations hosting the conferences. He is a director and shareholder of Clinvivo Ltd (Kent, UK), which provides electronic data collection for health services research. He is part of an academic partnership with Serco Group plc (Hook, UK), funded by the European Social Fund, related to return to work initiatives. He receives some salary support from University Hospitals Coventry and Warwickshire (Coventry, UK) and Martin Underwood is a co-investigator on three NIHR-funded studies, receiving additional support from Stryker Ltd (Newbury, UK). He has accepted honoraria for teaching/lecturing from consortium for advanced research training in Africa. Until March 2020, he was an editor of the NIHR journal series, and a member of the NIHR Journal Editors Group, for which he received a fee. Patrick White’s institution has received grant funding from the NIHR HTA programme, NIHR Health and Social Care Delivery Research (HSDR) programme, NIHR Research for Patient Benefit programme and NIHR In-Practice Fellowship programme. He participates in the Data Management and Ethics Committee for UKRI/NIHR Principle Trial (Oxford, UK), in the Trial Steering Committee for the Excalibur Trial (Southampton, UK) UKRI Innovate UK and in the Project Oversight Committee for the NIHR HSDR 17/99/72. He is a voluntary patron/trustee for Millennium Community Solutions (London, UK). Stephanie JC Taylor’s institution has received research grant funding from NIHR Applied Research Collaboration (ARC) North Thames (London, UK), and Barts Health NHS Trust (London, UK) provided some research capacity funding, which was used to bridge fund Dr Vari Wileman and this enabled her to contribute to the fidelity and process evaluation work on TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD). She received funding from NIHR ARC North Thames to fund her time [5% whole time equivalent (WTE)] for work on multimorbidity. TANDEM was adopted as an ARC project by the NIHR ARC North Thames Multimorbidity Themes. She has various other NIHR grants as chief investigator and co-applicant: NIHR Public Health Research (PHR) 19/03, RP-PG-1016-10014, RP-PG-1016-10012, RP-PG-0616-20002, RP-PG-0216-20001, HSDR NIHR 19/103, NIHR AI_AWARD02204, 223501/Z/21/Z and ‘PhD Programme for Primary Care Clinicians’. NIHR School for Primary Care Research pay 0.5 WTE of salary for the academic capacity development lead for the school. She was a member of HTA Clinical Evaluation and Trials Committee (2016–20) and is a member of NIHR Programme Grants for Applied Research Committee A (2021–present). She has a small number of AstraZeneca shares, representing < 3% of the value of her share portfolio.